Mounjaro – Medical Weight Loss Injections
Mounjaro is a once weekly injectable medication that can offer the support you need to reach your weight loss goals.
Mounjaro Price: $1399/month
Mounjaro is a brand-name version of the generic medication tirzepatide. It belongs to a class of medications called GLP-1 receptor agonists. These drugs are FDA-approved for managing certain symptoms and risks associated with type 2 diabetes. Mounjaro helps you lose weight by controlling your blood sugar and curbing your appetite. It activates natural hormones to stimulate insulin and reduce sugar levels, making it an effective option for weight management.
See other patients’ experiences at Web MD.
See the Tirzepatide vs placebo study by Lilly.
FDA Approved
Reduced Cravings
Improved Metabolic Health
Long-Termn Weight Management
On average patients lose ~35 pounds
GET STARTED
Book an in-home lab draw or walk into any Quest Diagnostics Lab near you. Processing Time: 1 week
Yes. Semaglutide, the drug used in Wegovy and Ozempic, has been shown to support weight loss and long-term weight management in multiple studies. Tirzepatide, the drug used in Mounjaro and Zepbound, has also proven to be highly effective at helping people lose weight.
All GLP-1s are clinically-tested, stimulant-free, and non-habit forming. GLP-1s address the underlying biology that is most important for weight loss, and help lower your set point, or the weight your body fights to stay at. GLP-1s are powerful, naturally-occurring hormones made by your gut that send signals to your brain to decrease your appetite, improve your metabolic system, and regulate your digestion so you can feel full longer and maximize nutrient absorption.
GLP-1s are powerful hormones made by your small intestine that send signals to your brain and other parts of your metabolic system. They regulate your insulin response and regulate your appetite and digestion so you can feel full longer while maximizing nutritional absorption.
In a 68-week medical study of 1,961 adults living with obesity or excess weight, and who also had a related medical problem, lost an average of 15% of their body weight while taking semaglutide. In a different study, tirzepatide helped patients lose 15 – 20% of their overall weight, depending on the dosage used.
Lab testing is part of the initial screening by your medical provider to ensure you are medically eligible for weight loss treatment. Biomarkers we test for include CMP, Fasting Lipid, TSH with Reflex to T4, Hemoglobin A1C, and Insulin.
GLP-1 use is safe and effective with many pre-existing conditions with the exception of the following:
Mounjaro Pens are administered in your thigh, abdomen, or upper arm. Please view these videos for further instructions. How to use Mounjaro Pen